medsovetМедицинский СоветMeditsinskiy sovet = Medical Council2079-701X2658-5790REMEDIUM GROUP Ltd.10.21518/2079-701X-2016-4-130-136medsovet-90Research ArticleГИНЕКОЛОГИЯGYNECOLOGYПрегравидарная подготовка женщин с невынашиванием беременности в анамнезеPregravid preparation for women with a history of miscarriageПустотинаО. А.PustotinaO. A.noemail@neicon.ruАхмедоваА. Э.AkhmedovaA. E.noemail@neicon.ruРоссийский университет дружбы народовРоссияRussian Peoples' Friendship UniversityRussian Federation20163012201604130136Copyright © Пустотина О.А., Ахмедова А.Э., 20162016Пустотина О.А., Ахмедова А.Э.Pustotina O.A., Akhmedova A.E.Данная работа распространяется под лицензией Creative Commons Attribution 4.0.This work is licensed under a Creative Commons Attribution 4.0 License.https://www.med-sovet.pro/jour/article/view/90

На основании анализа существующих международных и отечественных рекомендаций представлен обобщенный алгоритм прегравидарной подготовки женщин с невынашиванием беременности в анамнезе. Даны рекомендации по выявлению и коррекции основных этиологических факторов невынашивания с целью профилактики повторных потерь беременности и других акушерских и перинатальных осложнений.

Based on the analysis of the current global and national guidelines, the article offers a generalized algorithm for pregravid preparation of women with a history of miscarriage. There are recommendations on the identification and management of the main etiological factors of miscarriage to prevent recurrent pregnancy loss and other obstetric and perinatal complications.

прегравидарная подготовканевынашивание беременностипрогестеронpregravid preparationmiscarriageprogesteroneReferencesBergheLLa V. Early pregnancy loss: in book Obstetric Evidence Based Guidelines. Second Edition. New York: CRC Press, 2012: 142-149.BergheLLa V. Early pregnancy loss: in book Obstetric Evidence Based Guidelines. Second Edition. New York: CRC Press, 2012: 142-149.Howard JA. Carp. Recurrent pregnancy Loss: causes, controversies and treatment. Second edition. New York: CRC Press; 2015: 1-16.Howard JA. Carp. Recurrent pregnancy Loss: causes, controversies and treatment. Second edition. New York: CRC Press; 2015: 1-16.American Society for Reproductive Medicine. Evaluation and treatment of recurrent pregnancy Loss: a committee opinion. Fertil Steril, 2012, 98(5): 1103-11.American Society for Reproductive Medicine. Evaluation and treatment of recurrent pregnancy Loss: a committee opinion. Fertil Steril, 2012, 98(5): 1103-11.Jaslow CR, Carney JL, Kutteh WH. Diagnostic factors identified in 1020 women with two versus three or more recurrent pregnancy losses. Fertil Steril, 2010, 93: 1234-43.Jaslow CR, Carney JL, Kutteh WH. Diagnostic factors identified in 1020 women with two versus three or more recurrent pregnancy losses. Fertil Steril, 2010, 93: 1234-43.Клинические рекомендации. Акушерство и гинекология. 4-е изд., перераб. и доп. Под ред. В.Н. Серова, Г.Т. Сухих. М.: ГЭОТАР-Медиа, 2014: 62-104.Клинические рекомендации. Акушерство и гинекология. 4-е изд., перераб. и доп. Под ред. В.Н. Серова, Г.Т. Сухих. М.: ГЭОТАР-Медиа, 2014: 62-104.Lathi RB, Gray Hazard FK, Heerema-McKenney A et al. First trimester miscarriage evaluation. Semin Reprod Med, 2011: 29: 463-9.Lathi RB, Gray Hazard FK, Heerema-McKenney A et al. First trimester miscarriage evaluation. Semin Reprod Med, 2011: 29: 463-9.Berghella V. Preconception care: in book Obstetric Evidence Based Guidelines. 2nd Edition. Ed. by Berghella V. 2012: 1-11.Berghella V. Preconception care: in book Obstetric Evidence Based Guidelines. 2nd Edition. Ed. by Berghella V. 2012: 1-11.Jack BW, Culpepper L, Babcock J et al. Addressing preconception risks identified at the time of a negative pregnancy test: a randomized trial. J Fam Pract, 1998, 47: 33-38.Jack BW, Culpepper L, Babcock J et al. Addressing preconception risks identified at the time of a negative pregnancy test: a randomized trial. J Fam Pract, 1998, 47: 33-38.Rumbold A, Middleton P, Pan N, Crowther CA. Vitamin supplementation for preventing miscarriage. Cochrane Database Syst Rev, 2011, 1: CD004073.Rumbold A, Middleton P, Pan N, Crowther CA. Vitamin supplementation for preventing miscarriage. Cochrane Database Syst Rev, 2011, 1: CD004073.Ota E, Hori H, Mori R et al. Antenatal dietary education and supplementation to increase energy and protein intake. Cochrane Database Syst Rev, 2015, 6: CD000032.Ota E, Hori H, Mori R et al. Antenatal dietary education and supplementation to increase energy and protein intake. Cochrane Database Syst Rev, 2015, 6: CD000032.Lund M, Kamper-Jcrgensen M, Nielsen HS et al. Prognosis for live birth in women with recurrent miscarriage: What is the best measure of success? Obstet Gynecol, 2012, 119: 37-43.Lund M, Kamper-Jcrgensen M, Nielsen HS et al. Prognosis for live birth in women with recurrent miscarriage: What is the best measure of success? Obstet Gynecol, 2012, 119: 37-43.Boue A, Gallano P. A collaborative study of the segregation of inherited chromosome structural arrangements in 1356 prenatal diagnoses. Prenat Diagn., 1984, 4: 45-67.Boue A, Gallano P. A collaborative study of the segregation of inherited chromosome structural arrangements in 1356 prenatal diagnoses. Prenat Diagn., 1984, 4: 45-67.Grati FR, Barlocco A, Grimi B et al. Chromosome abnormalities investigated by non-invasive prenatal testing account for approximately 50% of fetal unbalances associated with relevant clinical phenotypes. Am J Med Genet A, 2010, 152A: 1434-42.Grati FR, Barlocco A, Grimi B et al. Chromosome abnormalities investigated by non-invasive prenatal testing account for approximately 50% of fetal unbalances associated with relevant clinical phenotypes. Am J Med Genet A, 2010, 152A: 1434-42.Carp HJA, Feldman B, Oelsner G et al. Parental karyotype and subsequent live births in recurrent miscarriage. Fertil Steril, 2004, 81: 1296-301.Carp HJA, Feldman B, Oelsner G et al. Parental karyotype and subsequent live births in recurrent miscarriage. Fertil Steril, 2004, 81: 1296-301.Werner M, Reh A, Grifo J et al. Characteristics of chromosomal abnormalities diagnosed after spontaneous abortions in an infertile population. J Assist Reprod Genet, 2012, 29: 817-20.Werner M, Reh A, Grifo J et al. Characteristics of chromosomal abnormalities diagnosed after spontaneous abortions in an infertile population. J Assist Reprod Genet, 2012, 29: 817-20.Sugiura-Ogasawara M, Ozaki Y, Katano K et al. Abnormal embryonic karyotype is the most frequent cause of recurrent miscarriage. Hum Reprod, 2012, 27: 2297-303.Sugiura-Ogasawara M, Ozaki Y, Katano K et al. Abnormal embryonic karyotype is the most frequent cause of recurrent miscarriage. Hum Reprod, 2012, 27: 2297-303.Chen I, Jhangri GS, Chandra S Relationship between interpregnancy interval and congenital anomalies. Am J Obstet Gynecol, 2014, 210(6): 564.e18.Chen I, Jhangri GS, Chandra S Relationship between interpregnancy interval and congenital anomalies. Am J Obstet Gynecol, 2014, 210(6): 564.e18.Sugiura-Ogasawara M, Ozaki Y, Katano K et al. Uterine anomaly and recurrent pregnancy loss. Semin Reprod Med, 2011, 29: 514-21.Sugiura-Ogasawara M, Ozaki Y, Katano K et al. Uterine anomaly and recurrent pregnancy loss. Semin Reprod Med, 2011, 29: 514-21.Jaslow CR, Kutteh WH. Effect of prior birth and miscarriage on the prevalence of acquired and congenital uterine anomalies in women with recurrent miscarriage: A cross-sectional study. Fertil Steril, 2013, 99: 1916-22.Jaslow CR, Kutteh WH. Effect of prior birth and miscarriage on the prevalence of acquired and congenital uterine anomalies in women with recurrent miscarriage: A cross-sectional study. Fertil Steril, 2013, 99: 1916-22.Ziakas PD, Pavlou M, Voulgarelis M. Heparin treatment in antiphospholipid syndrome with recurrent pregnancy loss: A systematic review and meta-analysis. Obstet Gynecol, 2010, 115: 1256-62.Ziakas PD, Pavlou M, Voulgarelis M. Heparin treatment in antiphospholipid syndrome with recurrent pregnancy loss: A systematic review and meta-analysis. Obstet Gynecol, 2010, 115: 1256-62.Laskin CA, Bombardier C, Hannah ME, et al. Prednisone and aspirin in women with autoan-tibodies and unexplained recurrent fetal loss. N Engl J Med, 1997, 337: 148-53.Laskin CA, Bombardier C, Hannah ME, et al. Prednisone and aspirin in women with autoan-tibodies and unexplained recurrent fetal loss. N Engl J Med, 1997, 337: 148-53.Porter TF, LaCoursiere Y, Scott JR. Immunotherapy for recurrent miscarriage. The Cochrane Database of Systemic Reviews, 2006: CD000112.Porter TF, LaCoursiere Y, Scott JR. Immunotherapy for recurrent miscarriage. The Cochrane Database of Systemic Reviews, 2006: CD000112.Hutton B, Sharma R, Fergusson D et al. Use of intravenous immunoglobulin for treatment of recurrent miscarriage: A systematic review. BJOG, 2007, 114: 134-42.Hutton B, Sharma R, Fergusson D et al. Use of intravenous immunoglobulin for treatment of recurrent miscarriage: A systematic review. BJOG, 2007, 114: 134-42.Silver R, Zhao Y, Spong Y et al. Prothrombin gene G20210A mutation and obstetric complications. Obstet Gynecol, 2010, 115: 14-20.Silver R, Zhao Y, Spong Y et al. Prothrombin gene G20210A mutation and obstetric complications. Obstet Gynecol, 2010, 115: 14-20.Said JM, Higgins J, Moses E et al. Inherited thrombophilia polymorphisms and pregnancy outcomes in nulliparous women. Obstet Gynecol, 2010, 115: 5-13.Said JM, Higgins J, Moses E et al. Inherited thrombophilia polymorphisms and pregnancy outcomes in nulliparous women. Obstet Gynecol, 2010, 115: 5-13.Virkus RA, Lokkegaard E, Lidegaard O et al. Risk Factors for Venous Thromboembolism in 1.3 Million Pregnancies: A Nationwide Prospective Cohort. PLoS ONE, 2014, 9(5): e96495.Virkus RA, Lokkegaard E, Lidegaard O et al. Risk Factors for Venous Thromboembolism in 1.3 Million Pregnancies: A Nationwide Prospective Cohort. PLoS ONE, 2014, 9(5): e96495.Lockwood C, Wendel G, Committee on Practice Bulletins-Obstetrics. Practice bulletin no. 124: Inherited thrombophilias in pregnancy. Obstet Gynecol, 2011, 118: 730-40.Lockwood C, Wendel G, Committee on Practice Bulletins-Obstetrics. Practice bulletin no. 124: Inherited thrombophilias in pregnancy. Obstet Gynecol, 2011, 118: 730-40.Airoldi JA. Inherited thrombophilia: in book Maternal-Fetal Evidence Based Guidelines. 2nd Edition. Ed. by Berghella V. 2012: 207-2014.Airoldi JA. Inherited thrombophilia: in book Maternal-Fetal Evidence Based Guidelines. 2nd Edition. Ed. by Berghella V. 2012: 207-2014.American College of Obstetricians and Gynecologists Inherited thrombophilias in pregnancy. Practice bulletin No. 113. Obstet Gynecol, 2010, 116: 212-222.American College of Obstetricians and Gynecologists Inherited thrombophilias in pregnancy. Practice bulletin No. 113. Obstet Gynecol, 2010, 116: 212-222.Vollset SE, Refsum H, Irgens LM, et al. Plasma total homocysteine, pregnancy complications, and adverse pregnancy outcomes: the Hordaland Homocysteine study. Am J Clin Nutr, 2000, 71: 962-968.Vollset SE, Refsum H, Irgens LM, et al. Plasma total homocysteine, pregnancy complications, and adverse pregnancy outcomes: the Hordaland Homocysteine study. Am J Clin Nutr, 2000, 71: 962-968.Wang X, Oin X, Demirtas H, Li J et al. Efficacy of folic acid supplementation in stroke prevention: a meta-analysis. Lancet, 2007, 369: 1876-82.Wang X, Oin X, Demirtas H, Li J et al. Efficacy of folic acid supplementation in stroke prevention: a meta-analysis. Lancet, 2007, 369: 1876-82.Penta M, Lukic A, Conte MP et al. Infectious agents in tissues from spontaneous abortions in the first trimester of pregnancy. New Microbiol, 2003, 26: 329-37.Penta M, Lukic A, Conte MP et al. Infectious agents in tissues from spontaneous abortions in the first trimester of pregnancy. New Microbiol, 2003, 26: 329-37.Bothuyne-Oueste E et al. Is the bacterial vagino-sis risk factor of prematurity? Study of a cohort of 1336 patients in the hospital of Arras. J Gynecol Obstet Biol Reprod, 2012, 41(3): 262-270.Bothuyne-Oueste E et al. Is the bacterial vagino-sis risk factor of prematurity? Study of a cohort of 1336 patients in the hospital of Arras. J Gynecol Obstet Biol Reprod, 2012, 41(3): 262-270.Гуртовой Б.Л., Кулаков В.И., Воропаева С.Д. Применение антибиотиков в акушерстве и гинекологии. М.: Триада-Х, 2004. 176 с.Гуртовой Б.Л., Кулаков В.И., Воропаева С.Д. Применение антибиотиков в акушерстве и гинекологии. М.: Триада-Х, 2004. 176 с.Colao A et al., Pregnancy outcomes following cabergoline treatment: extended results from a 12-year observational study. Clinical Endocrinology, 2008, 68: 66-71.Colao A et al., Pregnancy outcomes following cabergoline treatment: extended results from a 12-year observational study. Clinical Endocrinology, 2008, 68: 66-71.Melmed F et al. Diagnosis and Treatment of Hyperprolactinemia: An Endocrine Society Clinical Practice Guideline. JCEM, 2013.Melmed F et al. Diagnosis and Treatment of Hyperprolactinemia: An Endocrine Society Clinical Practice Guideline. JCEM, 2013.Клинические рекомендации Российской Ассоциации Эндокринологов (РАЭ). Гиперпролактинемия, 2013.Клинические рекомендации Российской Ассоциации Эндокринологов (РАЭ). Гиперпролактинемия, 2013.Poppe K, Velkeniers B, Glinoer D. Thyroid disease and female reproduction. Clin Endocrinol, 2007, 66: 309-21.Poppe K, Velkeniers B, Glinoer D. Thyroid disease and female reproduction. Clin Endocrinol, 2007, 66: 309-21.Soldin OP, Chung SH, Colie C. The Use of TSH in Determining Thyroid Disease: How Does It Impact the Practice of Medicine in Pregnancy? J Thyroid Re, 2013: 148-157.Soldin OP, Chung SH, Colie C. The Use of TSH in Determining Thyroid Disease: How Does It Impact the Practice of Medicine in Pregnancy? J Thyroid Re, 2013: 148-157.Melamed N, Hod M. Perinatal mortality in progestational diabetes. Int J Gynaecol Obstet, 2009, 104: S20-4.Melamed N, Hod M. Perinatal mortality in progestational diabetes. Int J Gynaecol Obstet, 2009, 104: S20-4.Ramin N, Thieme R, Fischer S et al. Maternal diabetes impairs gastrulation and insulin and IGF-I receptor expression in rabbit blastocysts. Endocrinology, 2010, 151: 4158-67.Ramin N, Thieme R, Fischer S et al. Maternal diabetes impairs gastrulation and insulin and IGF-I receptor expression in rabbit blastocysts. Endocrinology, 2010, 151: 4158-67.Gutaj P, Zawiejska A, Wender-Ozegowska E et al. Maternal factors predictive of first-trimester pregnancy loss in women with pregestational diabetes. Pol Arch Med Wewn, 2013, 123: 21-8.Gutaj P, Zawiejska A, Wender-Ozegowska E et al. Maternal factors predictive of first-trimester pregnancy loss in women with pregestational diabetes. Pol Arch Med Wewn, 2013, 123: 21-8.Maryam K, Bouzari Z, Basirat Z et al. The comparison of insulin resistance frequency in patients with recurrent early pregnancy loss to normal individuals. BMC Res Notes, 2012, 5: 133.Maryam K, Bouzari Z, Basirat Z et al. The comparison of insulin resistance frequency in patients with recurrent early pregnancy loss to normal individuals. BMC Res Notes, 2012, 5: 133.Goodman NF, Cobin RH, Futterweit W et al. American Association of Clinical Endocrinologists, American College of Endocrinology, and Androgen Excess and PCOS Society Disease State Clinical Review: Guide to the Best Practices in the Evaluation and Treatment of Polycystic Ovary Syndrome. Part 2. Endocr. Pract., 2015, 21(12): 1415-1426.Goodman NF, Cobin RH, Futterweit W et al. American Association of Clinical Endocrinologists, American College of Endocrinology, and Androgen Excess and PCOS Society Disease State Clinical Review: Guide to the Best Practices in the Evaluation and Treatment of Polycystic Ovary Syndrome. Part 2. Endocr. Pract., 2015, 21(12): 1415-1426.Синдром поликистозных яичников в репродуктивном возрасте (современные подходы к диагностике и лечению): Клинические рекомендации (протокол лечения). М.: Минздрав России, 2015. 22 с.Синдром поликистозных яичников в репродуктивном возрасте (современные подходы к диагностике и лечению): Клинические рекомендации (протокол лечения). М.: Минздрав России, 2015. 22 с.Evidence-based Methodology Workshop on Polycystic Ovary Syndrome December 3-5, 2012. 2012. Bethesda, Maryland: National Institutes of Health, 2012. 14 p.Evidence-based Methodology Workshop on Polycystic Ovary Syndrome December 3-5, 2012. 2012. Bethesda, Maryland: National Institutes of Health, 2012. 14 p.Oi O et al. Association of methylenetetrahydro-folate reductase gene polymorphisms with polycystic ovary syndrome. Chin. J. Med. Genet., 2015, 32(3): 400-404.Oi O et al. Association of methylenetetrahydro-folate reductase gene polymorphisms with polycystic ovary syndrome. Chin. J. Med. Genet., 2015, 32(3): 400-404.Chakraborty P, Goswami SK, Rajani S et al. Recurrent pregnancy loss in polycystic ovary syndrome: Role of hyperhomocysteinemia and insulin resistance. PLoS One, 2013, 8: e64446.Chakraborty P, Goswami SK, Rajani S et al. Recurrent pregnancy loss in polycystic ovary syndrome: Role of hyperhomocysteinemia and insulin resistance. PLoS One, 2013, 8: e64446.Kamenov Z. Ovulation induction with myo-ino-sitol alone and in combination with clomi-phene citrate in polycystic ovarian syndrome patients with insulin resistance. Gynecol Endocrinol. 2015; 31(2): 131-5Kamenov Z. Ovulation induction with myo-ino-sitol alone and in combination with clomi-phene citrate in polycystic ovarian syndrome patients with insulin resistance. Gynecol Endocrinol. 2015; 31(2): 131-5Lessey DA. Assessment of endometrial receptivity. Fertil Steril, 2011, 96: 522-529.Lessey DA. Assessment of endometrial receptivity. Fertil Steril, 2011, 96: 522-529.Johnson NP, Hummelshoj L for the World Endometriosis Society Montpellier. Consortium Consensus on current management of endo-metriosis. Hum Reprod, 2013, 28(6): 1552-1568.Johnson NP, Hummelshoj L for the World Endometriosis Society Montpellier. Consortium Consensus on current management of endo-metriosis. Hum Reprod, 2013, 28(6): 1552-1568.Wetendorf M, DeMayo FJ. The progesterone receptor regulates implantation, decidualiza-tion, and glandular development via a complex paracrine signaling network. Mol Cell Endocrinol, 2012, 357: 108-18.Wetendorf M, DeMayo FJ. The progesterone receptor regulates implantation, decidualiza-tion, and glandular development via a complex paracrine signaling network. Mol Cell Endocrinol, 2012, 357: 108-18.Bergquist A, Ferno M. Oestrogen and progesterone receptors in endometriotic tissue and endometrium: Comparison of different cycle phases and ages. Hum Reprod, 1993, 8: 2211-7.Bergquist A, Ferno M. Oestrogen and progesterone receptors in endometriotic tissue and endometrium: Comparison of different cycle phases and ages. Hum Reprod, 1993, 8: 2211-7.Clinical guidelines. Obstetrics and gynecology. 4th ed., rev. and enl. Ed. by V.N. Serov, G.T. Sukhikh. М.: GEOTAR-Media, 2014: 62-104.Clinical guidelines. Obstetrics and gynecology. 4th ed., rev. and enl. Ed. by V.N. Serov, G.T. Sukhikh. М.: GEOTAR-Media, 2014: 62-104.Gurtovoy B.L., Kulakov V.I., Voropaeva S.D. The use of antibiotics in obstetrics and gynecology. М.: Triada-H, 2004. 176 p.Gurtovoy B.L., Kulakov V.I., Voropaeva S.D. The use of antibiotics in obstetrics and gynecology. М.: Triada-H, 2004. 176 p.Clinical guidelines of the Russian Association of Endocrinologists (RAE). Hyperprolactinemia, 2013.Clinical guidelines of the Russian Association of Endocrinologists (RAE). Hyperprolactinemia, 2013.Polycystic ovary syndrome in reproductive age (current approaches to diagnosis and treatment): Clinical guidelines (treatment protocol). М.: Russian Ministry of Health, 2015. 22 p.Polycystic ovary syndrome in reproductive age (current approaches to diagnosis and treatment): Clinical guidelines (treatment protocol). М.: Russian Ministry of Health, 2015. 22 p.

The authors declare that there are no conflicts of interest present.